Why the study?
Do ketolide antibiotics like solithromycin reduce the risk of QT prolongation compared to traditional macrolides?
Do ketolide antibiotics like solithromycin reduce the risk of QT prolongation compared to traditional macrolides?
Ketolide antibiotics such as solithromycin should be considered over traditional macrolides in patients with a risk of QT prolongation.
Answers are grounded in this paper and cite their sources.
Structural modifications may mitigate macrolide QT risk; leaves open prospective confirmation before changing practice.
Solithromycin, a ketolide/macrolide antibiotic, has recently been reported to be free of the expected QT-prolonging effect of macrolides. It appears that its keto substitution provides a structural basis for this observation, as the other two tested ketolides also have minimal QT effect.Among non-cardiovascular therapies, antimicrobials probably carry the greatest potential to cause cardiac arrhythmias. This is a result of their propensity to bind to the delayed rectifier potassium channel, IKr, inducing QT prolongation and risk of torsades de pointes ventricular tachycardia, their frequent interference with the metabolism of other QT prolongers and their susceptibility to metabolic inhibition by numerous commonly used drugs.Unfortunately, there is evidence that medical practitioners do not take account of the QT/arrhythmia risk of antimicrobials in their prescribing practices. Education on this topic is sorely needed. When a macrolide is indicated, a ketolide should be considered in patients with a QT risk.
No takes yet. Share an insight, caveat, or question.
Jay W. Mason (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: